Skip to main content
Premium Trial:

Request an Annual Quote

Scripps Gets $3.8M from Qualcomm Foundation for Digital Medicine Effort

NEW YORK (GenomeWeb News) – Scripps Health today said that it has received a $3.75 million grant from the Qualcomm Foundation for digital medicine efforts, including genomic-based technologies, conducted at the Scripps Translational Science Institute.

The funds will be used to support a wide variety of efforts including the advancement of clinical trials for wireless biosensor systems, the development of pharmacogenomics tests that would be administered in retail stores, and apps and sensors for tracking and predicting heart attacks, type 1 diabetes, and cancer, said Scripps.

Part of the funding will be used to support an ongoing collaboration between Scripps, researchers at Imperial College London, and London-based DNA Electronics, which is developing electronic microchip-based tests for real-time nucleic acid detection. The partners are testing a point-of-care genotyping test to determine a patient's compatibility with drugs such as Plavix (clopidogrel), metformin, and interferon.

"The support from the Qualcomm Foundation of our efforts at Scripps positions us to catalyze the future of digital medicine – a new form of health care that is remarkably precise, tailored to individual patients, and designed to engage them in their own care," Scripps Chief Academic Officer and STSI Director Eric Topol said in a statement.

The Qualcomm Foundation was established in 2010 by San Diego-based wireless technologies firm Qualcomm.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.